UPDATE 2-J&J wins reversal of $72 mln verdict over talc cancer risks

Oct 17 (Reuters) - Johnson & Johnson on Tuesday won the reversal of a $72 million verdict in favor of the family of a woman whose death from ovarian cancer they claimed stemmed from her use of the company's talc-based products like Johnson's Baby Powder.